IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a.
Tsukaguchi
M
M
Tagawa
Y
Y
Takeuchi
H
H
Yuki
N
N
D000116:Acetylgalactosamine / Q000276:immunology*; D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D003429:Cross Reactions / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000276:immunology*; D005678:G(M2) Ganglioside / Q000276:immunology*; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D008297:Male; D011129:Polyradiculoneuropathy / Q000276:immunology*; D011971:Receptors, Immunologic / Q000276:immunology
D001323:Autoantibodies; D007075:Immunoglobulin M; D011971:Receptors, Immunologic; C037045:galactose-N-acetylgalactosamine receptor; D005678:G(M2) Ganglioside; D000116:Acetylgalactosamine